{"gene":"MSTN","run_date":"2026-06-10T02:59:51","timeline":{"discoveries":[{"year":1997,"finding":"Loss-of-function mutations in myostatin (GDF8) cause the double-muscled phenotype in cattle: Belgian Blue cattle carry an 11-bp deletion causing a frameshift that removes the conserved TGF-β domain, and Piedmontese cattle carry a G-A transition changing a conserved cysteine to tyrosine, establishing myostatin as a negative regulator of muscle growth.","method":"cDNA cloning, sequence analysis of normal vs. double-muscled cattle, expression profiling","journal":"Genome Research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct sequence analysis with functional interpretation, independently replicated across two cattle breeds, consistent with prior mouse targeted disruption data","pmids":["9314496"],"is_preprint":false},{"year":2005,"finding":"GDF8 activates the p38 MAPK pathway through TGF-β-activated kinase 1 (TAK1), independently of Smad signaling. GDF8-induced transcriptional activation was inhibited by dominant-negative MKK6 or p38 inhibitor SB203580, and ATF-2 was phosphorylated and detected in a complex with Smad3/Smad4 upon GDF8 treatment. p38 MAPK was required for GDF8-induced inhibition of proliferation and upregulation of p21.","method":"Dominant-negative MKK6 expression, pharmacological p38 inhibition (SB203580), co-immunoprecipitation of ATF-2/Smad3/Smad4 complex, transcriptional reporter assays, proliferation assays","journal":"Cellular Signalling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal functional approaches (DN overexpression + pharmacological inhibition + Co-IP), multiple orthogonal methods in single study","pmids":["15567067"],"is_preprint":false},{"year":2003,"finding":"GDF8 (myostatin) suppresses proliferation of porcine embryonic myogenic cells partly through upregulation of IGFBP-3; an anti-IGFBP-3 neutralizing antibody reduced GDF8-mediated proliferation suppression, indicating IGFBP-3 mediates part of GDF8's anti-proliferative effect in myogenic cells.","method":"Cell proliferation assays, IGFBP-3 protein/mRNA measurement, anti-IGFBP-3 neutralizing antibody treatment","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional antibody neutralization and mRNA/protein measurement, single lab, two orthogonal methods","pmids":["14502562"],"is_preprint":false},{"year":2007,"finding":"Loss of myostatin function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) in vitro; the type IIB activin receptor (AcvrIIB) is expressed on BMSCs. Recombinant myostatin decreased expression of osteogenic factors BMP-2 and IGF-1 in BMSCs during mechanical loading, and the increased osteogenic differentiation was ablated by hindlimb unloading in vivo.","method":"In vitro osteogenic differentiation assay, immunofluorescence for AcvrIIB on BMSCs, recombinant myostatin treatment, hindlimb unloading model","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function KO mice + recombinant protein treatment + in vivo unloading, single lab, multiple methods","pmids":["17383950"],"is_preprint":false},{"year":2008,"finding":"Myostatin deficiency increases fracture callus size, upregulates Sox-5 and BMP-2 expression in the fracture callus, and increases total osseous tissue area and callus strength, establishing myostatin as a regulator of fracture callus morphogenesis by inhibiting recruitment and proliferation of progenitor cells.","method":"Myostatin knockout mice, fibula osteotomy model, histomorphometry, three-point bending biomechanics, gene expression analysis","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with defined cellular and biomechanical phenotypes, single lab","pmids":["18852073"],"is_preprint":false},{"year":2010,"finding":"Myostatin (GDF-8) and its receptor ActRIIB are expressed in human anterior cruciate ligament (ACL) tissue. Recombinant myostatin treatment of primary ACL fibroblasts increased cell proliferation and upregulated tenascin C, type 1 collagen, and TGF-β1 expression, identifying myostatin as a pro-fibrogenic factor in ligament tissue.","method":"Real-time PCR, immunohistochemistry, recombinant myostatin treatment of primary ACL fibroblasts, myostatin KO mouse comparison","journal":"Journal of Orthopaedic Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro recombinant protein treatment with multiple readouts plus in vivo KO validation, single lab","pmids":["20186835"],"is_preprint":false},{"year":2014,"finding":"GDF8 signaling is inhibited by small molecule ATP-competitive inhibitors dorsomorphin and LDN-193189, which target GDF8-induced Smad2/3 signaling and repress myogenic transcription factors. Crystal structure of ActRIIA with dorsomorphin was resolved. Both inhibitors rescued myogenesis in GDF8-treated myoblasts and promoted contractile activity of myotubular networks.","method":"Crystal structure determination of ActRIIA with dorsomorphin, Smad2/3 phosphorylation assays, myoblast differentiation rescue assay, live cell contractility microscopy","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus functional rescue assays with multiple orthogonal methods, single lab","pmids":["25368322"],"is_preprint":false},{"year":2017,"finding":"GDF11 is a more potent activator of SMAD2/3 and signals more effectively through ALK4/5/7 than GDF8 despite high sequence similarity. Crystal structures of GDF11:FS288 complex, apo-GDF8, and apo-GDF11 revealed unique structural features in the type I receptor binding site of GDF11. Substitution of GDF11 residues into GDF8 conferred enhanced signaling activity to GDF8.","method":"SMAD2/3 signaling assays, crystal structure determination of GDF11:FS288, apo-GDF8, and apo-GDF11, chimeric protein mutagenesis","journal":"BMC Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal structures plus functional mutagenesis and signaling assays, orthogonal methods in single study","pmids":["28257634"],"is_preprint":false},{"year":2017,"finding":"GDF8 inhibits bone formation and promotes bone resorption in mice. In vitro, GDF8 negatively regulated primary osteoblasts and promoted RANKL-induced osteoclastogenesis. In vivo, intraperitoneal injection of recombinant GDF8 repressed bone formation and accelerated bone resorption; a GDF8 neutralizing antibody stimulated new bone formation and prevented bone resorption in aged mice.","method":"Primary osteoblast culture with recombinant GDF8, osteoclastogenesis assay, in vivo intraperitoneal injection, neutralizing antibody treatment","journal":"Clinical and Experimental Pharmacology and Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo gain-of-function and loss-of-function approaches, single lab","pmids":["28074479"],"is_preprint":false},{"year":2019,"finding":"WFIKKN2 follistatin domain (FSD) binds GDF8 and GDF11 and blocks their interaction with ActRIIB. Crystal structure of WFIKKN2 FSD was resolved to 1.39 Å; alanine substitution of surface-exposed residues reduced GDF8 antagonism. WFIKKN2 and follistatin both use their FSDs to block type II receptor binding but via different binding interactions.","method":"Native gel shift, surface plasmon resonance, crystal structure determination (1.39 Å), alanine scanning mutagenesis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus SPR binding assays plus functional mutagenesis, single lab, multiple orthogonal methods","pmids":["30814254"],"is_preprint":false},{"year":2021,"finding":"Tolloid-mediated activation of latent GDF8 requires specific residues adjacent to the scissile bond (D99) in the prodomain, particularly Y94 and D92. Alanine mutations at these positions abolished tolloid-mediated activation of latent GDF8. Prodomain mutants (D92A, Y94A) resisted proteolysis but could be fully activated under acidic conditions. Co-expression of tolloid-resistant GDF8 prodomain mutants with WT GDF8 suppressed WT GDF8 activity in a dominant-negative manner.","method":"Sequential alanine mutagenesis, recombinant protein production and purification, protease cleavage assay with astacin domain of Tll1, acidic activation assay, dominant-negative co-expression assay","journal":"Biochemical Journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis plus dominant-negative functional validation, single lab, multiple orthogonal methods","pmids":["33876824"],"is_preprint":false},{"year":2020,"finding":"MSTN mutation (loss of function) promotes myogenic differentiation by increasing expression of demethylase TET1 via the SMAD2/SMAD3 pathway; ChIP-qPCR demonstrated that the SMAD2/SMAD3 complex binds the TET1 promoter to inhibit TET1 transcription. MSTN mutation reduces methylation of PAX3, PAX7, MyoD, and MyoG promoters. Overexpression of TET1 in WT cells promoted myogenic differentiation; knockdown of TET1 in MSTN mutant cells reversed the pro-myogenic effects.","method":"ChIP-qPCR, bisulfite sequencing/methylation analysis, TET1 overexpression and siRNA knockdown, myotube fusion index measurement, satellite cell differentiation assay","journal":"International Journal of Biological Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus gain/loss-of-function and methylation analysis, single lab, multiple orthogonal methods","pmids":["32210722"],"is_preprint":false},{"year":2020,"finding":"GDF8 (myostatin) upregulates SERPINE1 expression in granulosa-lutein cells via the ALK5-mediated SMAD2/3-SMAD4 signaling pathway, leading to glucose metabolism defects. ERK1/2 signaling was also activated by GDF8 but did not mediate SERPINE1 expression. TP53 was required for GDF8-stimulated SERPINE1 upregulation.","method":"siRNA-mediated knockdown, pharmacological inhibition (SB-431542), transcriptome sequencing, glucose metabolism assays in hGL cells","journal":"Molecular Therapy: Nucleic Acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus pharmacological inhibition plus transcriptomics, single lab","pmids":["33425488"],"is_preprint":false},{"year":2020,"finding":"GDF8 promotes cell invasiveness in human extravillous cytotrophoblast cells by upregulating FSTL3 expression via the ALK5-SMAD2/3 signaling pathway.","method":"siRNA-mediated knockdown of pathway components, recombinant GDF8 treatment, invasion assays in immortalized and primary EVT cells","journal":"Frontiers in Cell and Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus functional invasion assay, single lab","pmids":["33195207"],"is_preprint":false},{"year":2021,"finding":"GDF-8 stimulates MMP2 expression (but not MMP9) in human EVT cells via the ALK5-SMAD2/3 signaling pathway, and GDF-8-induced cell invasiveness is dependent on MMP2 upregulation.","method":"siRNA-mediated knockdown of ALK5 and SMAD2/3, MMP2 knockdown, recombinant GDF-8 treatment, invasion assays","journal":"Reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus functional invasion assay plus negative result for MMP9, single lab","pmids":["34432647"],"is_preprint":false},{"year":2021,"finding":"GDF-8 stimulates aromatase (CYP19A1) expression and estradiol production in human granulosa-lutein cells via TGF-β type I receptor ALK5-mediated SMAD2/3 signaling. ALK5 inhibitor SB431542 reduced aromatase upregulation and alleviated OHSS symptoms in a rat model.","method":"Recombinant GDF-8 treatment, pharmacological ALK5 inhibition, rat OHSS model, human follicular fluid measurements, in vitro granulosa cell assays","journal":"International Journal of Biological Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro mechanistic dissection plus in vivo rat model validation, single lab","pmids":["34239360"],"is_preprint":false},{"year":2019,"finding":"MSTN deletion in cattle activates AMPK signaling pathways to regulate glucose and lipid metabolism, increasing activity of key enzymes in fatty acid β-oxidation and glycolysis, as shown by comparative proteomics and phosphoproteomics of MSTN-/- cattle muscle.","method":"Tandem mass tag (TMT) proteomic and phosphoproteomic analysis of MSTN-/- vs. WT cattle muscle, AMPK activity assays","journal":"General and Comparative Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — proteomics/phosphoproteomics plus AMPK activity assay, single lab, hypothesis-driven follow-up limited","pmids":["31374285"],"is_preprint":false},{"year":2019,"finding":"MSTN deletion in mice attenuates cardiac hypertrophy by inhibiting excessive cardiac autophagy through inactivation of AMPK/mTOR signaling and activation of the PPARγ/NF-κB pathway. MSTN also downregulates miR-128, which targets PPARγ to aggravate cardiac hypertrophy.","method":"AAC and angiotensin II cardiac hypertrophy models in MSTN-/- mice and WT mice, Western blot for AMPK/mTOR/PPARγ/NF-κB, miR-128 expression analysis, in vitro cardiomyocyte assays","journal":"Molecular Therapy: Nucleic Acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model plus in vitro mechanistic assays with multiple pathway readouts, single lab","pmids":["31923740"],"is_preprint":false},{"year":2017,"finding":"GDF8 activates p38 MAPK signaling during porcine oocyte maturation in vitro through ActRIIb and Alk4/5 receptors, which upon GDF8 recognition induce phosphorylation of p38 MAPK and alter transcription of cumulus expansion genes (Has2, Ptx3, TNFAIP6) and Nrf2/Bcl-2, leading to reduced intracellular ROS and improved embryonic developmental competence.","method":"Recombinant GDF8 supplementation in IVM, p38 MAPK phosphorylation assay, gene expression analysis in oocytes and cumulus cells, ROS measurement, IVF/PA embryo developmental assay","journal":"Theriogenology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor activation and downstream signaling with multiple functional readouts, single lab","pmids":["28708509"],"is_preprint":false},{"year":2020,"finding":"Mstn deletion in mice enhances bone mass by upregulating GDF11 expression, which activates BMP signaling to enhance osteogenesis; Gdf11 null mice show reduced bone mass through impaired osteoblast and chondrocyte maturation and increased osteoclastogenesis. Mice overexpressing follistatin show increased muscle mass but bone fractures due to GDF11 inhibition, unlike Mstn null mice.","method":"Mstn null mice, Gdf11 null mice, follistatin overexpressing mice; histomorphometry, gene expression, BMP signaling pathway analysis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (KO, overexpression) with defined cellular and signaling phenotypes, replicated across models","pmids":["32071240"],"is_preprint":false},{"year":2020,"finding":"A single amino acid deletion (cysteine 42) in the MSTN propeptide region, caused by a 3-bp deletion, results in increased body weight and muscle mass via muscle hyperplasia in quail, demonstrating the functional importance of cysteine 42 in regulating MSTN activity in avian species.","method":"CRISPR/Cas9 adenoviral gene editing in quail, body weight and muscle mass measurement, histological analysis of muscle fiber number and size","journal":"International Journal of Molecular Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO with defined phenotype, single lab","pmids":["32098368"],"is_preprint":false},{"year":2025,"finding":"GDF8 (myostatin) and activin A are the two major ActRIIA/B ligands mediating muscle mass minimization. Dual blockade of GDF8 and activin A prevents GLP-1 receptor agonist-associated muscle loss and increases muscle mass in obese mice and non-human primates, with enhanced fat loss.","method":"Dual antibody blockade of GDF8 and activin A in obese mouse and NHP models, body composition analysis","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with defined physiological phenotype in two species, single study","pmids":["40360507"],"is_preprint":false},{"year":2008,"finding":"GDF-8 expression in the mouse mammary gland is inversely correlated with differentiated state; highest GDF-8 mRNA levels occur during maximal ductal growth and diminish with pregnancy, reaching minimal levels at lactation. Unlike in muscle cells, GDF-8 did not reduce proliferation or induce p21 in mammary epithelial cells, revealing cell-type-specific activity.","method":"GDF-8 mRNA and protein expression profiling across mammary gland development stages, Smad2/3 phosphorylation assay, mammary epithelial cell proliferation assay, p21 induction assay","journal":"Molecular Reproduction and Development","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — expression profiling with functional assays in vitro, single lab","pmids":["18389502"],"is_preprint":false}],"current_model":"MSTN (GDF8/myostatin) is a secreted TGF-β superfamily member that acts as a potent negative regulator of skeletal muscle mass by signaling through type II activin receptors (ActRIIA/B) and type I receptors (ALK4/5) to activate SMAD2/3 transcriptional programs; it is synthesized as a latent complex held inactive by its prodomain, which is cleaved at D99 by tolloid-family metalloproteases (requiring residues Y94/D92) to release the active dimer; GDF8 also activates p38 MAPK via TAK1/MKK6 independently of Smad signaling, suppresses osteoblast differentiation while promoting osteoclastogenesis via ALK5-SMAD2/3, regulates fracture healing, trophoblast invasion (via FSTL3 and MMP2 upregulation through ALK5-SMAD2/3), granulosa cell aromatase expression, and cardiac autophagy through AMPK/mTOR and PPARγ/NF-κB pathways; its activity is antagonized extracellularly by follistatin, FSTL3, and WFIKKN2 (all blocking ActRIIB binding via their follistatin domains), and GDF11 shares receptors but is structurally distinct and more potent at SMAD2/3 activation due to differences in the type I receptor binding site."},"narrative":{"mechanistic_narrative":"MSTN (GDF8/myostatin) is a secreted TGF-β superfamily ligand that acts as a dominant negative regulator of skeletal muscle mass, established by loss-of-function mutations that remove or disrupt its conserved TGF-β domain and produce the double-muscled phenotype in cattle and muscle hyperplasia across species [PMID:9314496, PMID:32098368]. Myostatin circulates as a latent complex held inactive by its prodomain; release of the active dimer requires tolloid-family proteolysis at the scissile bond, which depends on prodomain residues Y94 and D92, and tolloid-resistant prodomain mutants act in a dominant-negative manner to suppress wild-type GDF8 [PMID:33876824]. The mature ligand signals through type II activin receptors (ActRIIB) and the type I receptor ALK5/ALK4 to drive SMAD2/3-SMAD4 transcription, which underlies its anti-myogenic action: GDF8-SMAD2/3 represses myogenic differentiation, and loss of MSTN de-represses myogenesis by elevating the demethylase TET1 and demethylating PAX3, PAX7, MyoD, and MyoG promoters [PMID:32210722, PMID:33425488, PMID:33195207]. In parallel to SMAD signaling, GDF8 activates p38 MAPK through TAK1 to inhibit proliferation and induce p21, and acts in part through IGFBP-3 to suppress myoblast proliferation [PMID:15567067, PMID:14502562]. Beyond muscle, ALK5-SMAD2/3 signaling mediates pleiotropic roles: GDF8 suppresses osteoblast differentiation and promotes osteoclastogenesis, regulates fracture callus formation, drives trophoblast invasion via FSTL3 and MMP2 upregulation, and stimulates granulosa-cell aromatase and SERPINE1 expression [PMID:28074479, PMID:18852073, PMID:33195207, PMID:34432647, PMID:34239360, PMID:33425488]. MSTN deletion engages AMPK-linked metabolic programs and attenuates cardiac hypertrophy through AMPK/mTOR and PPARγ/NF-κB pathways [PMID:31374285, PMID:31923740]. Its activity is antagonized extracellularly by follistatin and by the WFIKKN2 follistatin domain, both of which block ActRIIB binding, and the closely related ligand GDF11 shares its receptors but is a more potent SMAD2/3 activator owing to differences in the type I receptor binding site [PMID:30814254, PMID:28257634, PMID:32071240]. The receptor pharmacology is therapeutically tractable: ATP-competitive inhibitors of the receptor kinases and dual antibody blockade of GDF8 plus activin A increase muscle mass in vivo [PMID:25368322, PMID:40360507].","teleology":[{"year":1997,"claim":"Establishing that myostatin is a negative regulator of muscle growth answered whether a single secreted factor could constrain muscle mass, anchoring the entire field.","evidence":"cDNA cloning and sequence analysis of normal vs. double-muscled cattle showing TGF-β domain-disrupting mutations","pmids":["9314496"],"confidence":"High","gaps":["Did not define the receptor or downstream signaling cascade","Did not establish how the latent ligand is activated"]},{"year":2003,"claim":"Identifying IGFBP-3 as a mediator addressed how GDF8 suppresses myogenic proliferation beyond simple receptor engagement.","evidence":"Neutralizing antibody and mRNA/protein measurement in porcine embryonic myogenic cells","pmids":["14502562"],"confidence":"Medium","gaps":["IGFBP-3 accounts for only part of the anti-proliferative effect","Single species/cell system"]},{"year":2005,"claim":"Demonstrating a Smad-independent p38/TAK1 arm answered whether GDF8 acts solely through canonical SMAD transcription, revealing a parallel anti-proliferative branch.","evidence":"Dominant-negative MKK6, SB203580 inhibition, ATF-2/Smad3/Smad4 Co-IP, and reporter/proliferation assays","pmids":["15567067"],"confidence":"High","gaps":["Did not map how the receptor complex activates TAK1","Tissue-specific relevance not assessed"]},{"year":2007,"claim":"Extending myostatin action to bone showed it regulates mesenchymal lineage choice, broadening its role beyond myofibers.","evidence":"In vitro osteogenic differentiation of BMSCs with recombinant myostatin plus hindlimb unloading in KO mice","pmids":["17383950"],"confidence":"Medium","gaps":["Receptor and SMAD dependence in BMSCs not dissected","Indirect (loading) and direct effects not fully separated"]},{"year":2008,"claim":"Loss-of-function and tissue-specific expression studies established that myostatin restrains fracture callus formation and acts in a cell-type-dependent manner.","evidence":"KO mouse fracture model with histomorphometry/biomechanics, and mammary gland expression profiling with proliferation/p21 assays","pmids":["18852073","18389502"],"confidence":"Medium","gaps":["Cell-type-specific signaling differences (e.g. lack of p21 induction in mammary cells) unexplained","Direct progenitor targets not identified"]},{"year":2010,"claim":"Identifying pro-fibrogenic activity in ligament tissue established context-dependent stimulatory effects of myostatin, contrasting with its anti-proliferative muscle role.","evidence":"Recombinant myostatin treatment of primary ACL fibroblasts with collagen/tenascin/TGF-β1 readouts plus KO comparison","pmids":["20186835"],"confidence":"Medium","gaps":["Downstream signaling branch driving fibrogenesis not defined","In vivo ligament relevance limited"]},{"year":2014,"claim":"Resolving the ActRIIA structure with a small-molecule inhibitor and rescuing myogenesis answered whether GDF8 receptor kinase signaling is pharmacologically druggable.","evidence":"Crystal structure of ActRIIA with dorsomorphin plus Smad2/3 and myoblast contractility/differentiation rescue assays","pmids":["25368322"],"confidence":"High","gaps":["Inhibitors are not GDF8-selective","In vivo therapeutic window not established here"]},{"year":2017,"claim":"Structural comparison of GDF8 and GDF11 explained why two ligands sharing receptors differ in SMAD2/3 potency, localizing the difference to the type I receptor binding site.","evidence":"Crystal structures of GDF11:FS288, apo-GDF8 and apo-GDF11 plus chimeric mutagenesis and signaling assays","pmids":["28257634"],"confidence":"High","gaps":["Physiological consequences of potency differences in vivo not resolved","Does not address ligand-specific antagonist selectivity"]},{"year":2017,"claim":"Gain- and loss-of-function in bone and oocytes refined the receptor logic, showing GDF8 inhibits bone formation/promotes resorption and activates p38 during oocyte maturation via ActRIIb-ALK4/5.","evidence":"Recombinant GDF8/neutralizing antibody in osteoblast and osteoclastogenesis assays in vivo, and p38/ROS/gene-expression readouts in porcine IVM","pmids":["28074479","28708509"],"confidence":"Medium","gaps":["Direct versus indirect contributions to bone turnover not separated","Oocyte signaling mapped in a single species"]},{"year":2019,"claim":"Metabolic profiling of MSTN-null tissue and cardiac models established that myostatin loss reprograms AMPK-linked metabolism and limits pathological cardiac autophagy/hypertrophy.","evidence":"TMT proteomics/phosphoproteomics and AMPK assays in MSTN-/- cattle muscle; AAC/AngII hypertrophy models in MSTN-/- mice with AMPK/mTOR/PPARγ/NF-κB and miR-128 analysis","pmids":["31374285","31923740"],"confidence":"Medium","gaps":["Whether metabolic and cardiac effects are cell-autonomous or secondary to muscle change unresolved","Direct ligand-to-AMPK link not established"]},{"year":2019,"claim":"Resolving the WFIKKN2 follistatin domain structure clarified how multiple antagonists converge on blocking type II receptor binding through distinct interfaces.","evidence":"1.39 Å crystal structure, SPR binding, native gel shift, and alanine-scanning mutagenesis of WFIKKN2 FSD against GDF8/GDF11","pmids":["30814254"],"confidence":"High","gaps":["In vivo antagonist hierarchy among follistatin/FSTL3/WFIKKN2 not ranked","Ligand-selective antagonism not engineered"]},{"year":2020,"claim":"Mechanistic dissection across reproductive and muscle tissues established ALK5-SMAD2/3 as the shared conduit for GDF8 effects on trophoblast invasion, granulosa metabolism, and epigenetic control of myogenesis.","evidence":"siRNA/pharmacological pathway blockade with invasion, glucose, and ChIP/methylation assays in EVT, hGL, and satellite cells","pmids":["32210722","33425488","33195207"],"confidence":"Medium","gaps":["Each axis demonstrated in a single lab/cell system","How one ligand selects divergent transcriptional outputs per tissue is unexplained"]},{"year":2020,"claim":"Cross-species genetic editing and the GDF11-bone axis refined which residues control ligand activity and distinguished MSTN from GDF11 functionally in bone.","evidence":"CRISPR deletion of MSTN propeptide cysteine 42 in quail; Mstn-null, Gdf11-null and follistatin-overexpressing mice with histomorphometry and BMP signaling analysis","pmids":["32098368","32071240"],"confidence":"High","gaps":["How propeptide cysteine 42 alters latency/activation mechanistically not defined","GDF11-mediated bone compensation in human contexts untested"]},{"year":2021,"claim":"Defining the prodomain residues required for tolloid cleavage answered how the latent complex is converted to active ligand and revealed a dominant-negative mode for resistant prodomains.","evidence":"Sequential alanine mutagenesis with Tll1 astacin-domain cleavage, acidic activation, and dominant-negative co-expression assays; plus ALK5-SMAD2/3-dependent MMP2/aromatase studies in EVT and granulosa cells","pmids":["33876824","34432647","34239360"],"confidence":"High","gaps":["In vivo timing and location of tolloid activation not mapped","Whether dominant-negative prodomains are physiologically relevant unknown"]},{"year":2025,"claim":"Dual ligand blockade established GDF8 and activin A as the two principal ActRIIA/B ligands governing muscle mass and validated combined neutralization as a strategy to preserve muscle.","evidence":"Dual antibody blockade of GDF8 and activin A in obese mouse and non-human primate models with body composition analysis","pmids":["40360507"],"confidence":"Medium","gaps":["Relative contribution of GDF8 versus activin A not separated","Long-term and human efficacy not addressed"]},{"year":null,"claim":"How a single ligand specifies divergent tissue-specific transcriptional outcomes through a common ALK5-SMAD2/3 axis, and how latent activation is spatially and temporally controlled in vivo, remain open.","evidence":"No single study in the timeline reconciles cell-type-specific GDF8 outputs or maps endogenous activation dynamics","pmids":[],"confidence":"Low","gaps":["No mechanism explaining tissue-specific co-factor selection","No in vivo map of where/when tolloid activates latent GDF8","Selectivity determinants distinguishing GDF8 from activin A and GDF11 signaling in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,7,18,21]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,6,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,10]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,9,10]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,7,12,13,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,4,11,19,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,10]}],"complexes":[],"partners":["ACVR2B","ACVR1B","TGFBR1","FST","FSTL3","WFIKKN2","SMAD3","TLL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14793","full_name":"Growth/differentiation factor 8","aliases":["Myostatin"],"length_aa":375,"mass_kda":42.8,"function":"Acts specifically as a negative regulator of skeletal muscle growth","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O14793/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MSTN","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MSTN","total_profiled":1310},"omim":[{"mim_id":"614160","title":"MUSCLE HYPERTROPHY; MSLHP","url":"https://www.omim.org/entry/614160"},{"mim_id":"609101","title":"F-BOX ONLY PROTEIN 30; FBXO30","url":"https://www.omim.org/entry/609101"},{"mim_id":"605343","title":"FOLLISTATIN-LIKE 3; FSTL3","url":"https://www.omim.org/entry/605343"},{"mim_id":"604488","title":"TITIN-CAP; TCAP","url":"https://www.omim.org/entry/604488"},{"mim_id":"603936","title":"GROWTH/DIFFERENTIATION FACTOR 11; GDF11","url":"https://www.omim.org/entry/603936"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"skeletal muscle","ntpm":9.4},{"tissue":"tongue","ntpm":14.3}],"url":"https://www.proteinatlas.org/search/MSTN"},"hgnc":{"alias_symbol":[],"prev_symbol":["GDF8"]},"alphafold":{"accession":"O14793","domains":[{"cath_id":"2.10.90.10","chopping":"41-97_270-375","consensus_level":"high","plddt":83.551,"start":41,"end":375},{"cath_id":"2.60.40","chopping":"123-250","consensus_level":"high","plddt":85.133,"start":123,"end":250}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14793","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14793-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14793-F1-predicted_aligned_error_v6.png","plddt_mean":78.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MSTN","jax_strain_url":"https://www.jax.org/strain/search?query=MSTN"},"sequence":{"accession":"O14793","fasta_url":"https://rest.uniprot.org/uniprotkb/O14793.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14793/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14793"}},"corpus_meta":[{"pmid":"9314496","id":"PMC_9314496","title":"Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle.","date":"1997","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/9314496","citation_count":846,"is_preprint":false},{"pmid":"20190380","id":"PMC_20190380","title":"Myostatin (GDF-8) as a key factor linking muscle mass and bone structure.","date":"2010","source":"Journal of musculoskeletal & neuronal interactions","url":"https://pubmed.ncbi.nlm.nih.gov/20190380","citation_count":166,"is_preprint":false},{"pmid":"17383950","id":"PMC_17383950","title":"Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading.","date":"2007","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/17383950","citation_count":145,"is_preprint":false},{"pmid":"20098749","id":"PMC_20098749","title":"A sequence polymorphism in MSTN predicts sprinting ability and racing stamina in thoroughbred horses.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20098749","citation_count":144,"is_preprint":false},{"pmid":"26354037","id":"PMC_26354037","title":"Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26354037","citation_count":134,"is_preprint":false},{"pmid":"15567067","id":"PMC_15567067","title":"Regulation of GDF-8 signaling by the p38 MAPK.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15567067","citation_count":115,"is_preprint":false},{"pmid":"16849634","id":"PMC_16849634","title":"GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.","date":"2006","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/16849634","citation_count":112,"is_preprint":false},{"pmid":"28257634","id":"PMC_28257634","title":"Structural basis for potency differences between GDF8 and GDF11.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/28257634","citation_count":97,"is_preprint":false},{"pmid":"10610713","id":"PMC_10610713","title":"Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10610713","citation_count":90,"is_preprint":false},{"pmid":"19799595","id":"PMC_19799595","title":"Polymorphisms in the ovine myostatin gene (MSTN) and their association with growth and carcass traits in New Zealand Romney sheep.","date":"2009","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19799595","citation_count":82,"is_preprint":false},{"pmid":"19392824","id":"PMC_19392824","title":"A frameshift mutation in the coding region of the myostatin gene (MSTN) affects carcass conformation and fatness in Norwegian White Sheep (Ovis aries).","date":"2009","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19392824","citation_count":75,"is_preprint":false},{"pmid":"18852073","id":"PMC_18852073","title":"Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume.","date":"2008","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/18852073","citation_count":70,"is_preprint":false},{"pmid":"17996073","id":"PMC_17996073","title":"Evidence for multiple alleles effecting muscling and fatness at the ovine GDF8 locus.","date":"2007","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17996073","citation_count":64,"is_preprint":false},{"pmid":"32071240","id":"PMC_32071240","title":"GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32071240","citation_count":61,"is_preprint":false},{"pmid":"18462481","id":"PMC_18462481","title":"Two single nucleotide polymorphisms in the myostatin (GDF8) gene have significant association with muscle depth of commercial Charollais sheep.","date":"2008","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18462481","citation_count":58,"is_preprint":false},{"pmid":"24743319","id":"PMC_24743319","title":"Efficient generation of myostatin (MSTN) biallelic mutations in cattle using zinc finger nucleases.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743319","citation_count":57,"is_preprint":false},{"pmid":"27530319","id":"PMC_27530319","title":"Isozygous and selectable marker-free MSTN knockout cloned pigs generated by the combined use of CRISPR/Cas9 and Cre/LoxP.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27530319","citation_count":56,"is_preprint":false},{"pmid":"17890020","id":"PMC_17890020","title":"Myostatin (MSTN) gene duplications in Atlantic salmon (Salmo salar): evidence for different selective pressure on teleost MSTN-1 and -2.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17890020","citation_count":52,"is_preprint":false},{"pmid":"25368322","id":"PMC_25368322","title":"Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25368322","citation_count":48,"is_preprint":false},{"pmid":"29446146","id":"PMC_29446146","title":"CRISPR/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass.","date":"2018","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29446146","citation_count":48,"is_preprint":false},{"pmid":"32098368","id":"PMC_32098368","title":"Muscle Hyperplasia in Japanese Quail by Single Amino Acid Deletion in MSTN Propeptide.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32098368","citation_count":46,"is_preprint":false},{"pmid":"31923740","id":"PMC_31923740","title":"MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB.","date":"2019","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/31923740","citation_count":46,"is_preprint":false},{"pmid":"28852138","id":"PMC_28852138","title":"Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28852138","citation_count":42,"is_preprint":false},{"pmid":"34247443","id":"PMC_34247443","title":"Production of MSTN-mutated cattle without exogenous gene integration using CRISPR-Cas9.","date":"2021","source":"Biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34247443","citation_count":39,"is_preprint":false},{"pmid":"40360507","id":"PMC_40360507","title":"GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40360507","citation_count":37,"is_preprint":false},{"pmid":"32210722","id":"PMC_32210722","title":"MSTN Mutant Promotes Myogenic Differentiation by Increasing Demethylase TET1 Expression via the SMAD2/SMAD3 Pathway.","date":"2020","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32210722","citation_count":36,"is_preprint":false},{"pmid":"19251921","id":"PMC_19251921","title":"Investigations into the GDF8 g+6723G-A polymorphism in New Zealand Texel sheep.","date":"2009","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/19251921","citation_count":35,"is_preprint":false},{"pmid":"21872596","id":"PMC_21872596","title":"Whole body cortisol and expression of HSP70, IGF-I and MSTN in early development of sea bass subjected to heat shock.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21872596","citation_count":34,"is_preprint":false},{"pmid":"16100053","id":"PMC_16100053","title":"A directed search in the region of GDF8 for quantitative trait loci affecting carcass traits in Texel sheep.","date":"2005","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/16100053","citation_count":33,"is_preprint":false},{"pmid":"24479661","id":"PMC_24479661","title":"The A55T and K153R polymorphisms of MSTN gene are associated with the strength training-induced muscle hypertrophy among Han Chinese men.","date":"2014","source":"Journal of sports sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24479661","citation_count":32,"is_preprint":false},{"pmid":"34109474","id":"PMC_34109474","title":"Long-term, multidomain analyses to identify the breed and allelic effects in MSTN-edited pigs to overcome lameness and sustainably improve nutritional meat production.","date":"2021","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34109474","citation_count":32,"is_preprint":false},{"pmid":"21710248","id":"PMC_21710248","title":"Polymorphisms of myostatin gene (MSTN) in four goat breeds and their effects on Boer goat growth performance.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21710248","citation_count":32,"is_preprint":false},{"pmid":"33425488","id":"PMC_33425488","title":"Aberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33425488","citation_count":31,"is_preprint":false},{"pmid":"32679613","id":"PMC_32679613","title":"CRISPR/Cas9-mediated MSTN disruption accelerates the growth of Chinese Bama pigs.","date":"2020","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/32679613","citation_count":31,"is_preprint":false},{"pmid":"14504233","id":"PMC_14504233","title":"Mapping modifiers affecting muscularity of the myostatin mutant (Mstn(Cmpt-dl1Abc)) compact mouse.","date":"2003","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14504233","citation_count":31,"is_preprint":false},{"pmid":"28074479","id":"PMC_28074479","title":"GDF8 inhibits bone formation and promotes bone resorption in mice.","date":"2017","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28074479","citation_count":30,"is_preprint":false},{"pmid":"19731204","id":"PMC_19731204","title":"Myostatin (GDF8) single nucleotide polymorphisms in Nellore cattle.","date":"2009","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/19731204","citation_count":30,"is_preprint":false},{"pmid":"30242885","id":"PMC_30242885","title":"CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30242885","citation_count":30,"is_preprint":false},{"pmid":"27289021","id":"PMC_27289021","title":"Establishment and phenotypic analysis of an Mstn knockout rat.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27289021","citation_count":30,"is_preprint":false},{"pmid":"25246367","id":"PMC_25246367","title":"Effective RNA-silencing strategy of Lv-MSTN/GDF11 gene and its effects on the growth in shrimp, Litopenaeus vannamei.","date":"2014","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25246367","citation_count":30,"is_preprint":false},{"pmid":"30981084","id":"PMC_30981084","title":"Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.","date":"2019","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/30981084","citation_count":30,"is_preprint":false},{"pmid":"30922397","id":"PMC_30922397","title":"IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.","date":"2019","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/30922397","citation_count":30,"is_preprint":false},{"pmid":"30658164","id":"PMC_30658164","title":"Genotypic and allelic effects of the myostatin gene (MSTN) on carcass, meat quality, and biometric traits in Colored Polish Merino sheep.","date":"2018","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/30658164","citation_count":30,"is_preprint":false},{"pmid":"22714921","id":"PMC_22714921","title":"Molecular characterization of myostatin (MSTN) gene and association analysis with growth traits in the bighead carp (Aristichthys nobilis).","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22714921","citation_count":27,"is_preprint":false},{"pmid":"14502562","id":"PMC_14502562","title":"Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures.","date":"2003","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14502562","citation_count":27,"is_preprint":false},{"pmid":"31374285","id":"PMC_31374285","title":"Proteomics insights into the effects of MSTN on muscle glucose and lipid metabolism in genetically edited cattle.","date":"2019","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31374285","citation_count":27,"is_preprint":false},{"pmid":"21323579","id":"PMC_21323579","title":"Analysis of the single-nucleotide polymorphism in the 5'UTR and part of intron I of the sheep MSTN gene.","date":"2011","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21323579","citation_count":27,"is_preprint":false},{"pmid":"17551751","id":"PMC_17551751","title":"Characterization of amphioxus GDF8/11 gene, an archetype of vertebrate MSTN and GDF11.","date":"2007","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/17551751","citation_count":25,"is_preprint":false},{"pmid":"32276422","id":"PMC_32276422","title":"Effective MSTN Gene Knockout by AdV-Delivered CRISPR/Cas9 in Postnatal Chick Leg Muscle.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32276422","citation_count":25,"is_preprint":false},{"pmid":"29802684","id":"PMC_29802684","title":"CRISPR/Cas9-mediated specific integration of fat-1 at the goat MSTN locus.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29802684","citation_count":25,"is_preprint":false},{"pmid":"32481564","id":"PMC_32481564","title":"Effect of MSTN Mutation on Growth and Carcass Performance in Duroc x Meishan Hybrid Population.","date":"2020","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/32481564","citation_count":24,"is_preprint":false},{"pmid":"31819500","id":"PMC_31819500","title":"Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31819500","citation_count":24,"is_preprint":false},{"pmid":"35524183","id":"PMC_35524183","title":"Optimized Cas9:sgRNA delivery efficiently generates biallelic MSTN knockout sheep without affecting meat quality.","date":"2022","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35524183","citation_count":24,"is_preprint":false},{"pmid":"20186835","id":"PMC_20186835","title":"Role of myostatin (GDF-8) signaling in the human anterior cruciate ligament.","date":"2010","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/20186835","citation_count":24,"is_preprint":false},{"pmid":"32512638","id":"PMC_32512638","title":"Effects of electroporation treatment using different concentrations of Cas9 protein with gRNA targeting Myostatin (MSTN) genes on the development and gene editing of porcine zygotes.","date":"2020","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/32512638","citation_count":23,"is_preprint":false},{"pmid":"31963797","id":"PMC_31963797","title":"Myostatin (MSTN) Gene Indel Variation and Its Associations with Body Traits in Shaanbei White Cashmere Goat.","date":"2020","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/31963797","citation_count":22,"is_preprint":false},{"pmid":"31127166","id":"PMC_31127166","title":"Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31127166","citation_count":22,"is_preprint":false},{"pmid":"28708509","id":"PMC_28708509","title":"GDF8 activates p38 MAPK signaling during porcine oocyte maturation in vitro.","date":"2017","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/28708509","citation_count":21,"is_preprint":false},{"pmid":"25447910","id":"PMC_25447910","title":"Identification and expression characterization of the myostatin (MSTN) gene and association analysis with growth traits in the razor clam Sinonovacula constricta.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25447910","citation_count":21,"is_preprint":false},{"pmid":"19505313","id":"PMC_19505313","title":"An insertion in the coding region of the myostatin (MSTN) gene affects carcass conformation and fatness in the Norwegian Spaelsau (Ovis aries).","date":"2009","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/19505313","citation_count":21,"is_preprint":false},{"pmid":"19899116","id":"PMC_19899116","title":"Age-related changes in craniofacial morphology in GDF-8 (myostatin)-deficient mice.","date":"2010","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/19899116","citation_count":21,"is_preprint":false},{"pmid":"32165710","id":"PMC_32165710","title":"Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32165710","citation_count":20,"is_preprint":false},{"pmid":"33195207","id":"PMC_33195207","title":"GDF8 Promotes the Cell Invasiveness in Human Trophoblasts by Upregulating the Expression of Follistatin-Like 3 Through the ALK5-SMAD2/3 Signaling Pathway.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33195207","citation_count":20,"is_preprint":false},{"pmid":"31906236","id":"PMC_31906236","title":"Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction.","date":"2019","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31906236","citation_count":20,"is_preprint":false},{"pmid":"24197697","id":"PMC_24197697","title":"Targeted disruption of the sheep MSTN gene by engineered zinc-finger nucleases.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24197697","citation_count":20,"is_preprint":false},{"pmid":"30604488","id":"PMC_30604488","title":"The contribution of myostatin (MSTN) and additional modifying genetic loci to race distance aptitude in Thoroughbred horses racing in different geographic regions.","date":"2019","source":"Equine veterinary journal","url":"https://pubmed.ncbi.nlm.nih.gov/30604488","citation_count":20,"is_preprint":false},{"pmid":"36037573","id":"PMC_36037573","title":"Germline transmission of MSTN knockout cattle via CRISPR-Cas9.","date":"2022","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/36037573","citation_count":19,"is_preprint":false},{"pmid":"31414284","id":"PMC_31414284","title":"Inhibition of MSTN signal pathway may participate in LIPUS preventing bone loss in ovariectomized rats.","date":"2019","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31414284","citation_count":19,"is_preprint":false},{"pmid":"23613242","id":"PMC_23613242","title":"Polymorphisms of the myostatin gene (MSTN) and its relationship with growth traits in goat breeds.","date":"2013","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/23613242","citation_count":18,"is_preprint":false},{"pmid":"32156541","id":"PMC_32156541","title":"Mutation in myostatin 3'UTR promotes C2C12 myoblast proliferation and differentiation by blocking the translation of MSTN.","date":"2020","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32156541","citation_count":18,"is_preprint":false},{"pmid":"32829040","id":"PMC_32829040","title":"MSTN is a key mediator for low-intensity pulsed ultrasound preventing bone loss in hindlimb-suspended rats.","date":"2020","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/32829040","citation_count":18,"is_preprint":false},{"pmid":"29156385","id":"PMC_29156385","title":"Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.","date":"2017","source":"Breast (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/29156385","citation_count":17,"is_preprint":false},{"pmid":"39365728","id":"PMC_39365728","title":"A MSTNDel73C mutation with FGF5 knockout sheep by CRISPR/Cas9 promotes skeletal muscle myofiber hyperplasia.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39365728","citation_count":17,"is_preprint":false},{"pmid":"31265735","id":"PMC_31265735","title":"Expression of MSTN gene and its correlation with pectoralis muscle fiber traits in the domestic pigeons (Columba livia).","date":"2019","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/31265735","citation_count":17,"is_preprint":false},{"pmid":"18389502","id":"PMC_18389502","title":"Mammary gland differentiation inversely correlates with GDF-8 expression.","date":"2008","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/18389502","citation_count":17,"is_preprint":false},{"pmid":"30814254","id":"PMC_30814254","title":"Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30814254","citation_count":16,"is_preprint":false},{"pmid":"34432647","id":"PMC_34432647","title":"GDF-8 stimulates trophoblast cell invasion by inducing ALK5-SMAD2/3-mediated MMP2 expression.","date":"2021","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34432647","citation_count":16,"is_preprint":false},{"pmid":"25437444","id":"PMC_25437444","title":"MSTN, mTOR and FoxO4 are involved in the enhancement of breast muscle growth by methionine in broilers with lower hatching weight.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25437444","citation_count":16,"is_preprint":false},{"pmid":"24081623","id":"PMC_24081623","title":"Genetic variations in the myostatin gene (MSTN) in New Zealand sheep breeds.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24081623","citation_count":16,"is_preprint":false},{"pmid":"19533681","id":"PMC_19533681","title":"Characterization of myostatin/gdf8/11 in the starlet sea anemone Nematostella vectensis.","date":"2009","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/19533681","citation_count":15,"is_preprint":false},{"pmid":"26846723","id":"PMC_26846723","title":"Quantitative measurements of GDF-8 using immunoaffinity LC-MS/MS.","date":"2016","source":"Proteomics. Clinical applications","url":"https://pubmed.ncbi.nlm.nih.gov/26846723","citation_count":15,"is_preprint":false},{"pmid":"22666112","id":"PMC_22666112","title":"Assessment of tools for marker-assisted selection in a marine commercial species: significant association between MSTN-1 gene polymorphism and growth traits.","date":"2012","source":"TheScientificWorldJournal","url":"https://pubmed.ncbi.nlm.nih.gov/22666112","citation_count":15,"is_preprint":false},{"pmid":"30825707","id":"PMC_30825707","title":"GDF8 enhances SOX2 expression and blastocyst total cell number in porcine IVF embryo development.","date":"2019","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/30825707","citation_count":14,"is_preprint":false},{"pmid":"30267811","id":"PMC_30267811","title":"Effects of fasting and re-feeding on mstn and mstnb genes expressions in Cranoglanis bouderius.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30267811","citation_count":14,"is_preprint":false},{"pmid":"37709247","id":"PMC_37709247","title":"Resistance exercise alleviates dexamethasone-induced muscle atrophy via Sestrin2/MSTN pathway in C57BL/6J mice.","date":"2023","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37709247","citation_count":14,"is_preprint":false},{"pmid":"36292721","id":"PMC_36292721","title":"MSTN Regulatory Network in Mongolian Horse Muscle Satellite Cells Revealed with miRNA Interference Technologies.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36292721","citation_count":13,"is_preprint":false},{"pmid":"31073529","id":"PMC_31073529","title":"Label-Free LC-MS/MS Proteomics Analyses Reveal Proteomic Changes Accompanying MSTN KO in C2C12 Cells.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/31073529","citation_count":13,"is_preprint":false},{"pmid":"36360291","id":"PMC_36360291","title":"Association of Myostatin Gene Polymorphisms with Strength and Muscle Mass in Athletes: A Systematic Review and Meta-Analysis of the MSTN rs1805086 Mutation.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36360291","citation_count":12,"is_preprint":false},{"pmid":"23479163","id":"PMC_23479163","title":"Characterization of myostatin gene (MSTN) of Pekin duck and the association of its polymorphism with breast muscle traits.","date":"2013","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/23479163","citation_count":12,"is_preprint":false},{"pmid":"34453705","id":"PMC_34453705","title":"MSTN is an important myokine for weight-bearing training to attenuate bone loss in ovariectomized rats.","date":"2021","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34453705","citation_count":12,"is_preprint":false},{"pmid":"33846367","id":"PMC_33846367","title":"A highly prevalent SINE mutation in the myostatin (MSTN) gene promoter is associated with low circulating myostatin concentration in Thoroughbred racehorses.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33846367","citation_count":12,"is_preprint":false},{"pmid":"31302418","id":"PMC_31302418","title":"Significant body mass increase by oral administration of a cascade of shIL21-MSTN yeast-based DNA vaccine in mice.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31302418","citation_count":12,"is_preprint":false},{"pmid":"34239360","id":"PMC_34239360","title":"High ovarian GDF-8 levels contribute to elevated estradiol production in ovarian hyperstimulation syndrome by stimulating aromatase expression.","date":"2021","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34239360","citation_count":12,"is_preprint":false},{"pmid":"16624893","id":"PMC_16624893","title":"SNP identification and analysis in part of intron 2 of goat MSTN gene and variation within and among species.","date":"2006","source":"The Journal of heredity","url":"https://pubmed.ncbi.nlm.nih.gov/16624893","citation_count":12,"is_preprint":false},{"pmid":"33876824","id":"PMC_33876824","title":"Characterization of tolloid-mediated cleavage of the GDF8 procomplex.","date":"2021","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/33876824","citation_count":11,"is_preprint":false},{"pmid":"35268106","id":"PMC_35268106","title":"Differential Expression of MSTN Isoforms in Muscle between Broiler and Layer Chickens.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/35268106","citation_count":10,"is_preprint":false},{"pmid":"32045608","id":"PMC_32045608","title":"Functional identification and characterization of IpMSTNa, a novel orthologous myostatin (MSTN) gene in channel catfish Ictalurus punctatus.","date":"2020","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32045608","citation_count":10,"is_preprint":false},{"pmid":"24721142","id":"PMC_24721142","title":"Identification of two SNPs in myostatin (MSTN) gene of Takifugu rubripes and their association with growth traits.","date":"2014","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/24721142","citation_count":10,"is_preprint":false},{"pmid":"37042654","id":"PMC_37042654","title":"Production of MSTN Gene-Edited Embryos of Buffalo Using the CRISPR/Cas9 System and SCNT.","date":"2023","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/37042654","citation_count":9,"is_preprint":false},{"pmid":"35570234","id":"PMC_35570234","title":"Esophageal striated muscle hypertrophy and muscle fiber type transformation in MSTN knockout pigs.","date":"2022","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/35570234","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50660,"output_tokens":5994,"usd":0.120945,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14732,"output_tokens":5037,"usd":0.099793,"stage2_stop_reason":"end_turn"},"total_usd":0.220738,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Loss-of-function mutations in myostatin (GDF8) cause the double-muscled phenotype in cattle: Belgian Blue cattle carry an 11-bp deletion causing a frameshift that removes the conserved TGF-β domain, and Piedmontese cattle carry a G-A transition changing a conserved cysteine to tyrosine, establishing myostatin as a negative regulator of muscle growth.\",\n      \"method\": \"cDNA cloning, sequence analysis of normal vs. double-muscled cattle, expression profiling\",\n      \"journal\": \"Genome Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct sequence analysis with functional interpretation, independently replicated across two cattle breeds, consistent with prior mouse targeted disruption data\",\n      \"pmids\": [\"9314496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GDF8 activates the p38 MAPK pathway through TGF-β-activated kinase 1 (TAK1), independently of Smad signaling. GDF8-induced transcriptional activation was inhibited by dominant-negative MKK6 or p38 inhibitor SB203580, and ATF-2 was phosphorylated and detected in a complex with Smad3/Smad4 upon GDF8 treatment. p38 MAPK was required for GDF8-induced inhibition of proliferation and upregulation of p21.\",\n      \"method\": \"Dominant-negative MKK6 expression, pharmacological p38 inhibition (SB203580), co-immunoprecipitation of ATF-2/Smad3/Smad4 complex, transcriptional reporter assays, proliferation assays\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal functional approaches (DN overexpression + pharmacological inhibition + Co-IP), multiple orthogonal methods in single study\",\n      \"pmids\": [\"15567067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GDF8 (myostatin) suppresses proliferation of porcine embryonic myogenic cells partly through upregulation of IGFBP-3; an anti-IGFBP-3 neutralizing antibody reduced GDF8-mediated proliferation suppression, indicating IGFBP-3 mediates part of GDF8's anti-proliferative effect in myogenic cells.\",\n      \"method\": \"Cell proliferation assays, IGFBP-3 protein/mRNA measurement, anti-IGFBP-3 neutralizing antibody treatment\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional antibody neutralization and mRNA/protein measurement, single lab, two orthogonal methods\",\n      \"pmids\": [\"14502562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of myostatin function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) in vitro; the type IIB activin receptor (AcvrIIB) is expressed on BMSCs. Recombinant myostatin decreased expression of osteogenic factors BMP-2 and IGF-1 in BMSCs during mechanical loading, and the increased osteogenic differentiation was ablated by hindlimb unloading in vivo.\",\n      \"method\": \"In vitro osteogenic differentiation assay, immunofluorescence for AcvrIIB on BMSCs, recombinant myostatin treatment, hindlimb unloading model\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function KO mice + recombinant protein treatment + in vivo unloading, single lab, multiple methods\",\n      \"pmids\": [\"17383950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Myostatin deficiency increases fracture callus size, upregulates Sox-5 and BMP-2 expression in the fracture callus, and increases total osseous tissue area and callus strength, establishing myostatin as a regulator of fracture callus morphogenesis by inhibiting recruitment and proliferation of progenitor cells.\",\n      \"method\": \"Myostatin knockout mice, fibula osteotomy model, histomorphometry, three-point bending biomechanics, gene expression analysis\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with defined cellular and biomechanical phenotypes, single lab\",\n      \"pmids\": [\"18852073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Myostatin (GDF-8) and its receptor ActRIIB are expressed in human anterior cruciate ligament (ACL) tissue. Recombinant myostatin treatment of primary ACL fibroblasts increased cell proliferation and upregulated tenascin C, type 1 collagen, and TGF-β1 expression, identifying myostatin as a pro-fibrogenic factor in ligament tissue.\",\n      \"method\": \"Real-time PCR, immunohistochemistry, recombinant myostatin treatment of primary ACL fibroblasts, myostatin KO mouse comparison\",\n      \"journal\": \"Journal of Orthopaedic Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro recombinant protein treatment with multiple readouts plus in vivo KO validation, single lab\",\n      \"pmids\": [\"20186835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GDF8 signaling is inhibited by small molecule ATP-competitive inhibitors dorsomorphin and LDN-193189, which target GDF8-induced Smad2/3 signaling and repress myogenic transcription factors. Crystal structure of ActRIIA with dorsomorphin was resolved. Both inhibitors rescued myogenesis in GDF8-treated myoblasts and promoted contractile activity of myotubular networks.\",\n      \"method\": \"Crystal structure determination of ActRIIA with dorsomorphin, Smad2/3 phosphorylation assays, myoblast differentiation rescue assay, live cell contractility microscopy\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus functional rescue assays with multiple orthogonal methods, single lab\",\n      \"pmids\": [\"25368322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GDF11 is a more potent activator of SMAD2/3 and signals more effectively through ALK4/5/7 than GDF8 despite high sequence similarity. Crystal structures of GDF11:FS288 complex, apo-GDF8, and apo-GDF11 revealed unique structural features in the type I receptor binding site of GDF11. Substitution of GDF11 residues into GDF8 conferred enhanced signaling activity to GDF8.\",\n      \"method\": \"SMAD2/3 signaling assays, crystal structure determination of GDF11:FS288, apo-GDF8, and apo-GDF11, chimeric protein mutagenesis\",\n      \"journal\": \"BMC Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal structures plus functional mutagenesis and signaling assays, orthogonal methods in single study\",\n      \"pmids\": [\"28257634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GDF8 inhibits bone formation and promotes bone resorption in mice. In vitro, GDF8 negatively regulated primary osteoblasts and promoted RANKL-induced osteoclastogenesis. In vivo, intraperitoneal injection of recombinant GDF8 repressed bone formation and accelerated bone resorption; a GDF8 neutralizing antibody stimulated new bone formation and prevented bone resorption in aged mice.\",\n      \"method\": \"Primary osteoblast culture with recombinant GDF8, osteoclastogenesis assay, in vivo intraperitoneal injection, neutralizing antibody treatment\",\n      \"journal\": \"Clinical and Experimental Pharmacology and Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo gain-of-function and loss-of-function approaches, single lab\",\n      \"pmids\": [\"28074479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"WFIKKN2 follistatin domain (FSD) binds GDF8 and GDF11 and blocks their interaction with ActRIIB. Crystal structure of WFIKKN2 FSD was resolved to 1.39 Å; alanine substitution of surface-exposed residues reduced GDF8 antagonism. WFIKKN2 and follistatin both use their FSDs to block type II receptor binding but via different binding interactions.\",\n      \"method\": \"Native gel shift, surface plasmon resonance, crystal structure determination (1.39 Å), alanine scanning mutagenesis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus SPR binding assays plus functional mutagenesis, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"30814254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tolloid-mediated activation of latent GDF8 requires specific residues adjacent to the scissile bond (D99) in the prodomain, particularly Y94 and D92. Alanine mutations at these positions abolished tolloid-mediated activation of latent GDF8. Prodomain mutants (D92A, Y94A) resisted proteolysis but could be fully activated under acidic conditions. Co-expression of tolloid-resistant GDF8 prodomain mutants with WT GDF8 suppressed WT GDF8 activity in a dominant-negative manner.\",\n      \"method\": \"Sequential alanine mutagenesis, recombinant protein production and purification, protease cleavage assay with astacin domain of Tll1, acidic activation assay, dominant-negative co-expression assay\",\n      \"journal\": \"Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis plus dominant-negative functional validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"33876824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MSTN mutation (loss of function) promotes myogenic differentiation by increasing expression of demethylase TET1 via the SMAD2/SMAD3 pathway; ChIP-qPCR demonstrated that the SMAD2/SMAD3 complex binds the TET1 promoter to inhibit TET1 transcription. MSTN mutation reduces methylation of PAX3, PAX7, MyoD, and MyoG promoters. Overexpression of TET1 in WT cells promoted myogenic differentiation; knockdown of TET1 in MSTN mutant cells reversed the pro-myogenic effects.\",\n      \"method\": \"ChIP-qPCR, bisulfite sequencing/methylation analysis, TET1 overexpression and siRNA knockdown, myotube fusion index measurement, satellite cell differentiation assay\",\n      \"journal\": \"International Journal of Biological Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus gain/loss-of-function and methylation analysis, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"32210722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GDF8 (myostatin) upregulates SERPINE1 expression in granulosa-lutein cells via the ALK5-mediated SMAD2/3-SMAD4 signaling pathway, leading to glucose metabolism defects. ERK1/2 signaling was also activated by GDF8 but did not mediate SERPINE1 expression. TP53 was required for GDF8-stimulated SERPINE1 upregulation.\",\n      \"method\": \"siRNA-mediated knockdown, pharmacological inhibition (SB-431542), transcriptome sequencing, glucose metabolism assays in hGL cells\",\n      \"journal\": \"Molecular Therapy: Nucleic Acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus pharmacological inhibition plus transcriptomics, single lab\",\n      \"pmids\": [\"33425488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GDF8 promotes cell invasiveness in human extravillous cytotrophoblast cells by upregulating FSTL3 expression via the ALK5-SMAD2/3 signaling pathway.\",\n      \"method\": \"siRNA-mediated knockdown of pathway components, recombinant GDF8 treatment, invasion assays in immortalized and primary EVT cells\",\n      \"journal\": \"Frontiers in Cell and Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus functional invasion assay, single lab\",\n      \"pmids\": [\"33195207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GDF-8 stimulates MMP2 expression (but not MMP9) in human EVT cells via the ALK5-SMAD2/3 signaling pathway, and GDF-8-induced cell invasiveness is dependent on MMP2 upregulation.\",\n      \"method\": \"siRNA-mediated knockdown of ALK5 and SMAD2/3, MMP2 knockdown, recombinant GDF-8 treatment, invasion assays\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus functional invasion assay plus negative result for MMP9, single lab\",\n      \"pmids\": [\"34432647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GDF-8 stimulates aromatase (CYP19A1) expression and estradiol production in human granulosa-lutein cells via TGF-β type I receptor ALK5-mediated SMAD2/3 signaling. ALK5 inhibitor SB431542 reduced aromatase upregulation and alleviated OHSS symptoms in a rat model.\",\n      \"method\": \"Recombinant GDF-8 treatment, pharmacological ALK5 inhibition, rat OHSS model, human follicular fluid measurements, in vitro granulosa cell assays\",\n      \"journal\": \"International Journal of Biological Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro mechanistic dissection plus in vivo rat model validation, single lab\",\n      \"pmids\": [\"34239360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MSTN deletion in cattle activates AMPK signaling pathways to regulate glucose and lipid metabolism, increasing activity of key enzymes in fatty acid β-oxidation and glycolysis, as shown by comparative proteomics and phosphoproteomics of MSTN-/- cattle muscle.\",\n      \"method\": \"Tandem mass tag (TMT) proteomic and phosphoproteomic analysis of MSTN-/- vs. WT cattle muscle, AMPK activity assays\",\n      \"journal\": \"General and Comparative Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — proteomics/phosphoproteomics plus AMPK activity assay, single lab, hypothesis-driven follow-up limited\",\n      \"pmids\": [\"31374285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MSTN deletion in mice attenuates cardiac hypertrophy by inhibiting excessive cardiac autophagy through inactivation of AMPK/mTOR signaling and activation of the PPARγ/NF-κB pathway. MSTN also downregulates miR-128, which targets PPARγ to aggravate cardiac hypertrophy.\",\n      \"method\": \"AAC and angiotensin II cardiac hypertrophy models in MSTN-/- mice and WT mice, Western blot for AMPK/mTOR/PPARγ/NF-κB, miR-128 expression analysis, in vitro cardiomyocyte assays\",\n      \"journal\": \"Molecular Therapy: Nucleic Acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model plus in vitro mechanistic assays with multiple pathway readouts, single lab\",\n      \"pmids\": [\"31923740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GDF8 activates p38 MAPK signaling during porcine oocyte maturation in vitro through ActRIIb and Alk4/5 receptors, which upon GDF8 recognition induce phosphorylation of p38 MAPK and alter transcription of cumulus expansion genes (Has2, Ptx3, TNFAIP6) and Nrf2/Bcl-2, leading to reduced intracellular ROS and improved embryonic developmental competence.\",\n      \"method\": \"Recombinant GDF8 supplementation in IVM, p38 MAPK phosphorylation assay, gene expression analysis in oocytes and cumulus cells, ROS measurement, IVF/PA embryo developmental assay\",\n      \"journal\": \"Theriogenology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor activation and downstream signaling with multiple functional readouts, single lab\",\n      \"pmids\": [\"28708509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mstn deletion in mice enhances bone mass by upregulating GDF11 expression, which activates BMP signaling to enhance osteogenesis; Gdf11 null mice show reduced bone mass through impaired osteoblast and chondrocyte maturation and increased osteoclastogenesis. Mice overexpressing follistatin show increased muscle mass but bone fractures due to GDF11 inhibition, unlike Mstn null mice.\",\n      \"method\": \"Mstn null mice, Gdf11 null mice, follistatin overexpressing mice; histomorphometry, gene expression, BMP signaling pathway analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (KO, overexpression) with defined cellular and signaling phenotypes, replicated across models\",\n      \"pmids\": [\"32071240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A single amino acid deletion (cysteine 42) in the MSTN propeptide region, caused by a 3-bp deletion, results in increased body weight and muscle mass via muscle hyperplasia in quail, demonstrating the functional importance of cysteine 42 in regulating MSTN activity in avian species.\",\n      \"method\": \"CRISPR/Cas9 adenoviral gene editing in quail, body weight and muscle mass measurement, histological analysis of muscle fiber number and size\",\n      \"journal\": \"International Journal of Molecular Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO with defined phenotype, single lab\",\n      \"pmids\": [\"32098368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GDF8 (myostatin) and activin A are the two major ActRIIA/B ligands mediating muscle mass minimization. Dual blockade of GDF8 and activin A prevents GLP-1 receptor agonist-associated muscle loss and increases muscle mass in obese mice and non-human primates, with enhanced fat loss.\",\n      \"method\": \"Dual antibody blockade of GDF8 and activin A in obese mouse and NHP models, body composition analysis\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with defined physiological phenotype in two species, single study\",\n      \"pmids\": [\"40360507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF-8 expression in the mouse mammary gland is inversely correlated with differentiated state; highest GDF-8 mRNA levels occur during maximal ductal growth and diminish with pregnancy, reaching minimal levels at lactation. Unlike in muscle cells, GDF-8 did not reduce proliferation or induce p21 in mammary epithelial cells, revealing cell-type-specific activity.\",\n      \"method\": \"GDF-8 mRNA and protein expression profiling across mammary gland development stages, Smad2/3 phosphorylation assay, mammary epithelial cell proliferation assay, p21 induction assay\",\n      \"journal\": \"Molecular Reproduction and Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — expression profiling with functional assays in vitro, single lab\",\n      \"pmids\": [\"18389502\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MSTN (GDF8/myostatin) is a secreted TGF-β superfamily member that acts as a potent negative regulator of skeletal muscle mass by signaling through type II activin receptors (ActRIIA/B) and type I receptors (ALK4/5) to activate SMAD2/3 transcriptional programs; it is synthesized as a latent complex held inactive by its prodomain, which is cleaved at D99 by tolloid-family metalloproteases (requiring residues Y94/D92) to release the active dimer; GDF8 also activates p38 MAPK via TAK1/MKK6 independently of Smad signaling, suppresses osteoblast differentiation while promoting osteoclastogenesis via ALK5-SMAD2/3, regulates fracture healing, trophoblast invasion (via FSTL3 and MMP2 upregulation through ALK5-SMAD2/3), granulosa cell aromatase expression, and cardiac autophagy through AMPK/mTOR and PPARγ/NF-κB pathways; its activity is antagonized extracellularly by follistatin, FSTL3, and WFIKKN2 (all blocking ActRIIB binding via their follistatin domains), and GDF11 shares receptors but is structurally distinct and more potent at SMAD2/3 activation due to differences in the type I receptor binding site.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MSTN (GDF8/myostatin) is a secreted TGF-β superfamily ligand that acts as a dominant negative regulator of skeletal muscle mass, established by loss-of-function mutations that remove or disrupt its conserved TGF-β domain and produce the double-muscled phenotype in cattle and muscle hyperplasia across species [#0, #20]. Myostatin circulates as a latent complex held inactive by its prodomain; release of the active dimer requires tolloid-family proteolysis at the scissile bond, which depends on prodomain residues Y94 and D92, and tolloid-resistant prodomain mutants act in a dominant-negative manner to suppress wild-type GDF8 [#10]. The mature ligand signals through type II activin receptors (ActRIIB) and the type I receptor ALK5/ALK4 to drive SMAD2/3-SMAD4 transcription, which underlies its anti-myogenic action: GDF8-SMAD2/3 represses myogenic differentiation, and loss of MSTN de-represses myogenesis by elevating the demethylase TET1 and demethylating PAX3, PAX7, MyoD, and MyoG promoters [#11, #12, #13]. In parallel to SMAD signaling, GDF8 activates p38 MAPK through TAK1 to inhibit proliferation and induce p21, and acts in part through IGFBP-3 to suppress myoblast proliferation [#1, #2]. Beyond muscle, ALK5-SMAD2/3 signaling mediates pleiotropic roles: GDF8 suppresses osteoblast differentiation and promotes osteoclastogenesis, regulates fracture callus formation, drives trophoblast invasion via FSTL3 and MMP2 upregulation, and stimulates granulosa-cell aromatase and SERPINE1 expression [#8, #4, #13, #14, #15, #12]. MSTN deletion engages AMPK-linked metabolic programs and attenuates cardiac hypertrophy through AMPK/mTOR and PPARγ/NF-κB pathways [#16, #17]. Its activity is antagonized extracellularly by follistatin and by the WFIKKN2 follistatin domain, both of which block ActRIIB binding, and the closely related ligand GDF11 shares its receptors but is a more potent SMAD2/3 activator owing to differences in the type I receptor binding site [#9, #7, #19]. The receptor pharmacology is therapeutically tractable: ATP-competitive inhibitors of the receptor kinases and dual antibody blockade of GDF8 plus activin A increase muscle mass in vivo [#6, #21].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that myostatin is a negative regulator of muscle growth answered whether a single secreted factor could constrain muscle mass, anchoring the entire field.\",\n      \"evidence\": \"cDNA cloning and sequence analysis of normal vs. double-muscled cattle showing TGF-β domain-disrupting mutations\",\n      \"pmids\": [\"9314496\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the receptor or downstream signaling cascade\", \"Did not establish how the latent ligand is activated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying IGFBP-3 as a mediator addressed how GDF8 suppresses myogenic proliferation beyond simple receptor engagement.\",\n      \"evidence\": \"Neutralizing antibody and mRNA/protein measurement in porcine embryonic myogenic cells\",\n      \"pmids\": [\"14502562\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"IGFBP-3 accounts for only part of the anti-proliferative effect\", \"Single species/cell system\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating a Smad-independent p38/TAK1 arm answered whether GDF8 acts solely through canonical SMAD transcription, revealing a parallel anti-proliferative branch.\",\n      \"evidence\": \"Dominant-negative MKK6, SB203580 inhibition, ATF-2/Smad3/Smad4 Co-IP, and reporter/proliferation assays\",\n      \"pmids\": [\"15567067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map how the receptor complex activates TAK1\", \"Tissue-specific relevance not assessed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extending myostatin action to bone showed it regulates mesenchymal lineage choice, broadening its role beyond myofibers.\",\n      \"evidence\": \"In vitro osteogenic differentiation of BMSCs with recombinant myostatin plus hindlimb unloading in KO mice\",\n      \"pmids\": [\"17383950\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor and SMAD dependence in BMSCs not dissected\", \"Indirect (loading) and direct effects not fully separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Loss-of-function and tissue-specific expression studies established that myostatin restrains fracture callus formation and acts in a cell-type-dependent manner.\",\n      \"evidence\": \"KO mouse fracture model with histomorphometry/biomechanics, and mammary gland expression profiling with proliferation/p21 assays\",\n      \"pmids\": [\"18852073\", \"18389502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific signaling differences (e.g. lack of p21 induction in mammary cells) unexplained\", \"Direct progenitor targets not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying pro-fibrogenic activity in ligament tissue established context-dependent stimulatory effects of myostatin, contrasting with its anti-proliferative muscle role.\",\n      \"evidence\": \"Recombinant myostatin treatment of primary ACL fibroblasts with collagen/tenascin/TGF-β1 readouts plus KO comparison\",\n      \"pmids\": [\"20186835\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling branch driving fibrogenesis not defined\", \"In vivo ligament relevance limited\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolving the ActRIIA structure with a small-molecule inhibitor and rescuing myogenesis answered whether GDF8 receptor kinase signaling is pharmacologically druggable.\",\n      \"evidence\": \"Crystal structure of ActRIIA with dorsomorphin plus Smad2/3 and myoblast contractility/differentiation rescue assays\",\n      \"pmids\": [\"25368322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Inhibitors are not GDF8-selective\", \"In vivo therapeutic window not established here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Structural comparison of GDF8 and GDF11 explained why two ligands sharing receptors differ in SMAD2/3 potency, localizing the difference to the type I receptor binding site.\",\n      \"evidence\": \"Crystal structures of GDF11:FS288, apo-GDF8 and apo-GDF11 plus chimeric mutagenesis and signaling assays\",\n      \"pmids\": [\"28257634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequences of potency differences in vivo not resolved\", \"Does not address ligand-specific antagonist selectivity\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Gain- and loss-of-function in bone and oocytes refined the receptor logic, showing GDF8 inhibits bone formation/promotes resorption and activates p38 during oocyte maturation via ActRIIb-ALK4/5.\",\n      \"evidence\": \"Recombinant GDF8/neutralizing antibody in osteoblast and osteoclastogenesis assays in vivo, and p38/ROS/gene-expression readouts in porcine IVM\",\n      \"pmids\": [\"28074479\", \"28708509\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect contributions to bone turnover not separated\", \"Oocyte signaling mapped in a single species\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Metabolic profiling of MSTN-null tissue and cardiac models established that myostatin loss reprograms AMPK-linked metabolism and limits pathological cardiac autophagy/hypertrophy.\",\n      \"evidence\": \"TMT proteomics/phosphoproteomics and AMPK assays in MSTN-/- cattle muscle; AAC/AngII hypertrophy models in MSTN-/- mice with AMPK/mTOR/PPARγ/NF-κB and miR-128 analysis\",\n      \"pmids\": [\"31374285\", \"31923740\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether metabolic and cardiac effects are cell-autonomous or secondary to muscle change unresolved\", \"Direct ligand-to-AMPK link not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolving the WFIKKN2 follistatin domain structure clarified how multiple antagonists converge on blocking type II receptor binding through distinct interfaces.\",\n      \"evidence\": \"1.39 Å crystal structure, SPR binding, native gel shift, and alanine-scanning mutagenesis of WFIKKN2 FSD against GDF8/GDF11\",\n      \"pmids\": [\"30814254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo antagonist hierarchy among follistatin/FSTL3/WFIKKN2 not ranked\", \"Ligand-selective antagonism not engineered\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mechanistic dissection across reproductive and muscle tissues established ALK5-SMAD2/3 as the shared conduit for GDF8 effects on trophoblast invasion, granulosa metabolism, and epigenetic control of myogenesis.\",\n      \"evidence\": \"siRNA/pharmacological pathway blockade with invasion, glucose, and ChIP/methylation assays in EVT, hGL, and satellite cells\",\n      \"pmids\": [\"32210722\", \"33425488\", \"33195207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each axis demonstrated in a single lab/cell system\", \"How one ligand selects divergent transcriptional outputs per tissue is unexplained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cross-species genetic editing and the GDF11-bone axis refined which residues control ligand activity and distinguished MSTN from GDF11 functionally in bone.\",\n      \"evidence\": \"CRISPR deletion of MSTN propeptide cysteine 42 in quail; Mstn-null, Gdf11-null and follistatin-overexpressing mice with histomorphometry and BMP signaling analysis\",\n      \"pmids\": [\"32098368\", \"32071240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How propeptide cysteine 42 alters latency/activation mechanistically not defined\", \"GDF11-mediated bone compensation in human contexts untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defining the prodomain residues required for tolloid cleavage answered how the latent complex is converted to active ligand and revealed a dominant-negative mode for resistant prodomains.\",\n      \"evidence\": \"Sequential alanine mutagenesis with Tll1 astacin-domain cleavage, acidic activation, and dominant-negative co-expression assays; plus ALK5-SMAD2/3-dependent MMP2/aromatase studies in EVT and granulosa cells\",\n      \"pmids\": [\"33876824\", \"34432647\", \"34239360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo timing and location of tolloid activation not mapped\", \"Whether dominant-negative prodomains are physiologically relevant unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Dual ligand blockade established GDF8 and activin A as the two principal ActRIIA/B ligands governing muscle mass and validated combined neutralization as a strategy to preserve muscle.\",\n      \"evidence\": \"Dual antibody blockade of GDF8 and activin A in obese mouse and non-human primate models with body composition analysis\",\n      \"pmids\": [\"40360507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of GDF8 versus activin A not separated\", \"Long-term and human efficacy not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single ligand specifies divergent tissue-specific transcriptional outcomes through a common ALK5-SMAD2/3 axis, and how latent activation is spatially and temporally controlled in vivo, remain open.\",\n      \"evidence\": \"No single study in the timeline reconciles cell-type-specific GDF8 outputs or maps endogenous activation dynamics\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No mechanism explaining tissue-specific co-factor selection\", \"No in vivo map of where/when tolloid activates latent GDF8\", \"Selectivity determinants distinguishing GDF8 from activin A and GDF11 signaling in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 7, 18, 21]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 6, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 9, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 7, 12, 13, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 4, 11, 19, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ACVR2B\", \"ACVR1B\", \"TGFBR1\", \"FST\", \"FSTL3\", \"WFIKKN2\", \"SMAD3\", \"TLL1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}